Vishal Kothari

2.9k total citations
31 papers, 908 citations indexed

About

Vishal Kothari is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Vishal Kothari has authored 31 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Vishal Kothari's work include Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (5 papers) and Enzyme-mediated dye degradation (4 papers). Vishal Kothari is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (5 papers) and Enzyme-mediated dye degradation (4 papers). Vishal Kothari collaborates with scholars based in United States, India and Canada. Vishal Kothari's co-authors include Felix Y. Feng, Joseph R. Evans, Arul M. Chinnaiyan, John R. Prensner, Matthew K. Iyer, Theodore S. Lawrence, Wei Chen, Sumin Han, Karen E. Knudsen and Chandan Kumar‐Sinha and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Vishal Kothari

30 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vishal Kothari United States 14 630 462 181 171 70 31 908
Jun Qian China 14 603 1.0× 353 0.8× 192 1.1× 192 1.1× 68 1.0× 23 946
Liangliang Ren China 22 823 1.3× 467 1.0× 206 1.1× 191 1.1× 51 0.7× 43 1.1k
Alexandra Debernardi France 8 950 1.5× 206 0.4× 175 1.0× 188 1.1× 79 1.1× 8 1.1k
Lee Sam United States 10 787 1.2× 311 0.7× 198 1.1× 57 0.3× 125 1.8× 13 1.1k
Naoya Uematsu Japan 14 1.0k 1.6× 213 0.5× 182 1.0× 426 2.5× 55 0.8× 18 1.2k
M. Rohan Fernando United States 15 666 1.1× 443 1.0× 103 0.6× 157 0.9× 33 0.5× 18 966
Teng‐Kuei Hsu United States 8 381 0.6× 213 0.5× 96 0.5× 212 1.2× 74 1.1× 9 644
Deli Hong United States 19 757 1.2× 293 0.6× 61 0.3× 264 1.5× 67 1.0× 25 971
Margaret L. Hoang United States 12 525 0.8× 238 0.5× 115 0.6× 138 0.8× 121 1.7× 19 923

Countries citing papers authored by Vishal Kothari

Since Specialization
Citations

This map shows the geographic impact of Vishal Kothari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishal Kothari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishal Kothari more than expected).

Fields of papers citing papers by Vishal Kothari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishal Kothari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishal Kothari. The network helps show where Vishal Kothari may publish in the future.

Co-authorship network of co-authors of Vishal Kothari

This figure shows the co-authorship network connecting the top 25 collaborators of Vishal Kothari. A scholar is included among the top collaborators of Vishal Kothari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishal Kothari. Vishal Kothari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panja, Sukanya, Mihai I. Truica, Christina Y. Yu, et al.. (2024). Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature Communications. 15(1). 352–352. 9 indexed citations
2.
Faisal, Farzana A., Sanjana Murali, Harsimar Kaur, et al.. (2020). CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer. Clinical Cancer Research. 26(11). 2595–2602. 23 indexed citations
3.
Kothari, Vishal, et al.. (2019). Toxicity Assessment of Biologically Degraded Product of Textile Dye Acid Red G. Defence Life Science Journal. 4(4). 236–243. 2 indexed citations
4.
Chen, William S., Rahul Aggarwal, Li Zhang, et al.. (2019). Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 146–146. 11 indexed citations
5.
Tomar, Rukam S., et al.. (2019). Genome Sequence Analysis and Identification of Genes Associated to Pesticide Degradation from Enterobacter cloacae Strain MR2. International Journal of Current Microbiology and Applied Sciences. 8(1). 2289–2304. 4 indexed citations
6.
Speers, Corey, Shuang G. Zhao, Benjamin C. Chandler, et al.. (2017). Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer. npj Breast Cancer. 3(1). 29–29. 49 indexed citations
7.
Shankar, Sunita, Sethuramasundaram Pitchiaya, Rohit Malik, et al.. (2016). KRAS Engages AGO2 to Enhance Cellular Transformation. Cell Reports. 14(6). 1448–1461. 34 indexed citations
8.
Speers, Corey, Shuang G. Zhao, Vishal Kothari, et al.. (2016). Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer. Clinical Cancer Research. 22(23). 5864–5875. 82 indexed citations
9.
Feng, Felix Y., Yu Zhang, Vishal Kothari, et al.. (2016). MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Neoplasia. 18(4). 213–222. 47 indexed citations
10.
Zhao, Shuang G., Joseph R. Evans, Vishal Kothari, et al.. (2015). The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer. Clinical Cancer Research. 22(7). 1777–1786. 43 indexed citations
11.
Gajera, H. P., et al.. (2015). Leaf proteome alterations in tolerant pearl millet (Pennisetum glaucumL.) genotype under water stress. International Journal of Agriculture Environment and Biotechnology. 8(3). 539–539. 3 indexed citations
12.
Zhao, Shuang G., Will Jackson, Vishal Kothari, et al.. (2015). High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Prostate Cancer and Prostatic Diseases. 18(3). 229–236. 8 indexed citations
13.
14.
Prensner, John R., Wei Chen, Sumin Han, et al.. (2014). The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc. Neoplasia. 16(11). 900–908. 200 indexed citations
15.
Kothari, Vishal, Ramesh K. Kothari, Charmy Kothari, et al.. (2014). Genome Sequence of Salt-Tolerant Bacillus safensis Strain VK, Isolated from Saline Desert Area of Gujarat, India. Genome Announcements. 2(2). 2 indexed citations
16.
Kothari, Vishal, Sunita Shankar, Shanker Kalyana‐Sundaram, et al.. (2013). Outlier Kinase Expression by RNA Sequencing as Targets for Precision Therapy. Cancer Discovery. 3(3). 280–293. 29 indexed citations
17.
Lau, K.‐H. William, Vishal Kothari, Amitava Das, Xiao‐Bing Zhang, & David J. Baylink. (2013). Cellular and molecular mechanisms of accelerated fracture healing by COX2 gene therapy. Bone. 53(2). 369–381. 26 indexed citations
18.
Jain, Tarun, et al.. (2012). Evolutionary Modular Neural Network Approach for Breast Cancer Diagnosis. 11 indexed citations
19.
Kalyana‐Sundaram, Shanker, Chandan Kumar‐Sinha, Sunita Shankar, et al.. (2012). Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers. Cell. 149(7). 1622–1634. 208 indexed citations
20.
Kothari, Vishal, et al.. (2009). HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus‐HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model. International Journal of Cancer. 126(3). 733–742. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026